3654 results for «382»
3654 results
Diffuse multivessel disease
05 Jul 2019 – From AICT-AsiaPCR 2019
TAVI in a bicuspid aortic valve stenosis
05 Jul 2019 – From AICT-AsiaPCR 2019
Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...
Opening - LIVE demonstration from National University Heart Centre Singapore
04 Jul 2019 – From AICT-AsiaPCR 2019
Calcified left main lesion PCI
05 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.
Complex distal left main bifurcation lesion
04 Jul 2019 – From AICT-AsiaPCR 2019
A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…
AICT-AsiaPCR Opening Ceremony
04 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations.
LAD/D1 bifurcation disease
06 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with LAD/D1 bifurcation disease.
A patient with LAD-diagonal bifurcation lesion
22 May 2019 – From EuroPCR 2019
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
Evidence base: current data on TAVI durability and long-term outcomes
18 Jun 2026
This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.
Author
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
